0001144204-13-055367.txt : 20131016
0001144204-13-055367.hdr.sgml : 20131016
20131016093517
ACCESSION NUMBER: 0001144204-13-055367
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131014
FILED AS OF DATE: 20131016
DATE AS OF CHANGE: 20131016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070336
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-624-7000
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RA Capital Healthcare Fund LP
CENTRAL INDEX KEY: 0001315082
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 131153282
BUSINESS ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6177782500
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER NAME:
FORMER CONFORMED NAME: RA Capital Biotech Fund LP
DATE OF NAME CHANGE: 20050121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kolchinsky Peter
CENTRAL INDEX KEY: 0001384859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 131153283
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001346824
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 131153284
BUSINESS ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-778-2500
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
v357407_form4.xml
OWNERSHIP DOCUMENT
X0306
4
2013-10-14
0
0001070336
ACHILLION PHARMACEUTICALS INC
ACHN
0001346824
RA CAPITAL MANAGEMENT, LLC
C/O RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON
MA
02116
0
0
1
1
See Footnotes (1)-(9)
0001384859
Kolchinsky Peter
C/O RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON
MA
02116
0
0
1
1
See Footnotes (1)-(9)
0001315082
RA Capital Healthcare Fund LP
C/O RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON
MA
02116
0
0
1
1
See Footnotes (1)-(9)
Common Stock, $0.001 par value
2013-10-14
4
P
0
81200
2.7550
A
16986971
I
See Footnotes
Common Stock, $0.001 par value
2013-10-14
4
P
0
13200
2.7650
A
17000171
I
See Footnotes
Common Stock, $0.001 par value
2013-10-14
4
P
0
475699
2.7718
A
17475870
I
See Footnotes
Common Stock, $0.001 par value
2013-10-14
4
P
0
230100
2.7750
A
17705970
I
See Footnotes
Common Stock, $0.001 par value
2013-10-14
4
P
0
950000
2.7895
A
18655970
I
See Footnotes
Common Stock, $0.001 par value
2013-10-14
4
P
0
206000
2.8000
A
18861970
I
See Footnotes
Common Stock, $0.001 par value
2013-10-14
4
P
0
369900
2.8352
A
19231870
I
See Footnotes
Common Stock, $0.001 par value
2013-10-14
4
P
0
43130
2.8540
A
19275000
I
See Footnotes
The securities purchased include 63,743 shares for RA Capital Healthcare Fund, L.P. (the "Fund") and 17,457 shares for an account owned by Blackwell Partners, LLC (the "Blackwell Account").
The securities purchased include 10,363 shares for the Fund and 2,837 shares for the Blackwell Account.
The securities purchased include 373,424 shares for the Fund and 102,275 shares for the Blackwell Account.
The securities purchased include 180,633 shares for the Fund and 49,467 shares for the Blackwell Account.
The securities purchased include 745,752 shares for the Fund and 204,248 shares for the Blackwell Account.
The securities purchased include 161,713 shares for the Fund and 44,287 shares for the Blackwell Account.
The securities purchased include 290,373 shares for the Fund and 79,527 shares for the Blackwell Account.
The securities purchased include 33,844 shares for the Fund and 9,286 shares for the Blackwell Account.
Following the transactions set forth on Table I above, 14,899,145 shares are held by the Fund, and 4,375,855 shares are held in the Blackwell Account.
RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Blackwell Account. Peter Kolchinsky is the sole manager of the Adviser. In their respective capacities, each of Mr. Kolchinsky and the Adviser may be deemed to beneficially own the reported securities.
Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interests therein. The filing of this Form 4 shall not be construed as an admission that Mr. Kolchinsky or the Adviser is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of securities reported herein.
/s/ Peter Kolchinsky, Manager of RA Capital Management, LLC
2013-10-16
/s/ Peter Kolchinsky, individually
2013-10-16
/s/ Peter Kolchinsky, Manager of RA Capital Management, LLC, the General Partner of RA Capital Healthcare Fund, L.P.
2013-10-16